explore
Previous article:
How to save PrEP access — and even expand it
Next article: FDA approves world's first CRISPR
Next article: FDA approves world's first CRISPR
leisure time
focus
-
AbbVie buys Immunogen, maker of targeted cancer drugs, for $10B
2025-10-01 22:36 -
'Make People Better': The CRISPR babies story you probably don't know
2025-10-01 22:11 -
What PEPFAR has meant on the ground in Ukraine
2025-10-01 21:27 -
FDA approves world's first CRISPR
2025-10-01 21:10 -
How to protect patients from sexual assault
2025-10-01 21:00 -
A rare thyroid diagnosis led to unexpected, all
2025-10-01 20:37